Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZLD115
Cat. No.:
OB0425LY-172
Appearance:
Solid
Purity:
99.24%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
ZLD115 is a small molecule compound with the ability to selectively fight against specific targets.
Synonyms:
ZLD-115; 2980653-93-6; 2-((1,4-Oxazepan-4-yl)methyl)-6-((2-chloro-6-cyclopropyl-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)benzoic acid;
CAS No.:
2980653-93-6
Compound CID:
168475863
Formula:
C27H30ClN3O4
Formula Weight:
496
Specification
Target:
Fat mass and obesity-associated protein (FTO)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
ZLD115 can be used for leukemia and obesity inhibitor development.
